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Chronic pain is a problem that affects around one million New Zealanders and is very difficult 
to treat effectively. Most pain management programmes focus on decreasing levels of 
treatment outcome measures (pain catastrophising, pain intensity, interference) and 
increasing levels of pain self-efficacy. Research shows that higher levels of vulnerabilities 
(depression, anxiety, stress, pessimism) can negatively impact treatment outcomes. 
However, research also shows that increasing levels of strengths (optimism, hope, 
spirituality, social support, grit) affect treatment outcomes positively. We wanted to 
determine if there were differences in treatment outcomes for participants with high levels of 
vulnerabilities or strengths. Our study looked at the relationships between treatment 
outcome measures, vulnerabilities, and strengths over a three-week pain management 
programme. Participants (N = 40) attending the ReCharge Programme at QE Health 
completed repeat measure scales at intake, discharge, and 12-week follow-up. We found 
that higher levels of depression, stress, and pessimism were associated with higher levels of 
pain catastrophising, pain intensity, and interference, and lower levels of pain self-efficacy. 
Conversely, higher levels of optimism, hope, spirituality, and grit were associated with lower 
levels catastrophising, intensity, and interference, and higher levels of pain self-efficacy. 
Anxiety and social support were not associated with any treatment outcomes. We also found 
that correlations of composite measures of strengths accounted for more variability in pain 
self-efficacy than did composite vulnerabilities. This suggests that tailored interventions, 
based on levels of strengths at intake, aimed at increasing levels of strengths during the 
ReCharge Programme could improve treatment outcome measures for clients. 
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One in five New Zealanders lives with chronic pain, that is nearly one million 
people, and I am one of them. In 2010, I severely damaged my back and in 2012, I 
underwent surgery to fuse three of my vertebrae together. Unfortunately, in 2013, I was 
told nothing further could be done. Although the surgery had stabilised my spine it had not 
had any effect on my pain levels, which were debilitating. In 2014, I attended the 
ReCharge Programme, a three-week pain management programme, at the Queen 
Elizabeth Hospital (QE Health) in Rotorua. I found this programme really helpful, however, 
many people with chronic pain did not see the same positive gains that I did. I became 
interested in the possible reasons for the notable difference in these outcomes.  
Chronic pain is a major problem in New Zealand and abroad, and it is a problem 
that is only growing worse. The most recent New Zealand Health Survey states that in the 
New Zealand population prevalence rates of chronic pain have increased from 17% in 
2005/6 to 21% in 2015/16 (Cox, 2016). Some of the reasons for the increased prevalence 
could be due to: our aging population - many elderly people are affected by chronic pain 
associated with arthritis and cancer (Webster, 2019) - increasing levels of obesity puts 
extra pressure on joints, and the increased number of hours spent sitting at a desk. 
Whatever the reason, chronic pain is impacting millions of people, and the impacts are not 
only related to health but also have a substantial economic effect.  
Chronic pain was estimated to cost New Zealand $13 to $14 billion in 2016 and 
Jones (2019) predicted that these figures will rise to $21 to $24 billion over the next 30 
years. Despite the substantial personal and societal costs of chronic pain there are very 




complex and subjective nature of chronic pain makes it difficult to treat effectively (Bonica, 
1980). Given these limitations, further research needs to be conducted into the most 
effective ways of treating chronic pain. In order to treat chronic pain, we must first 
understand what chronic pain is. 
A History of Pain Theories 
Chronic pain is commonly defined as pain that has persisted for three to six 
months and/or is present almost every day (Cox, 2016; Kennedy & Abd-Elsayed, 2019; 
Treede et al., 2015). Acute pain is an essential adaptive function which serves to protect 
the body from harm, however, chronic pain persists past the point when healing would be 
expected and causes significant psychological distress and functional impairment (Treede 
et al., 2019). Pain is more than just a physiological response, it also has psychological, 
cognitive, and emotional elements. Over the past 200 years, there have been some 
seminal theories concerning how and why we experience chronic pain. These include the 
Specificity Theory, the Pattern Theory, the Gate Control Theory, and the Neuromatrix 
Theory (Trachsel & Cascella, 2019). 
 In his insightful 1664 manuscript, Treatise of Man, Descartes described the dual 
aspects of pain as a sensory transmission (nociception) and as a perceptual experience 
(pain) (Descartes, 1664). Descartes conceptualised nerves as tubes conveying motor and 
sensory information with a gate between the hollow tubes and the brain. This gate could 
be opened by a tug on the nerve or sensory cue resulting in movement . This theory, 
however, did not explain how the brain processed the sensory information or why the 
perceptual experience of pain differed from person to person.  
Nearly 150 years later, Charles Bell developed the Specificity Theory in which he 
postulated that different nerves had different functions (Bell & Shaw, 1868). Rather than 
conceptualising the brain as a solid homogenous structure, as Descartes had, Bell 
proposed that messages travelled specific pathways along nerves to the brain depending 




designated areas of the brain, as if they were a single strand following the pathway from 
the site of the stimulus to the specific pain reception area in the brain. In contrast, the 
Pattern Theory of pain suggested by Nafe (1929) stated that it was the pattern of different 
nerves firing which culminated in the perception of pain. According to the Pattern Theory 
all nerve endings experienced every different sensory stimulus (heat, cold, pain) which 
were conveyed to different regions of the brain. The intensity and sensation were then 
processed according to the pattern they generated in the different regions, which in turn 
was believed to be perceived as pain. We now know that there are different nerve 
receptors for different sensations, including a unique receptor for pain (Melzack, 1999). 
The Gate Control Theory (Melzack & Wall, 1965) was the first theory of pain to 
combine aspects of both the Specificity Theory and the Pattern Theory. This new 
conceptualisation of pain changed the focus of pain research (Moayedi & Davis, 2012). 
Melzack and Wall (1965) proposed that there are two types of nerves: small diameter 
afferent nerves which transmit pain signals (nociceptive) and large diameter afferent 
nerves which transmit vibration and touch signals (non-nociceptive). Both types of nerves 
terminate in the dorsal horn area of the spine in either transmission cells or inhibitory 
interneurons. Transmission cells carry the pain signal to the brain whereas inhibitory 
interneurons impede the transmission of the pain signal (Melzack & Wall, 1965). 
Therefore, increased input from the non-nociceptive nerves can close the gate between 
the dorsal horn and the brain, effectively cancelling out the input from the nociceptive 
nerves. Pain signals can travel from the site of the injury to the brain and also from the 
brain down the spinal cord (Melzack & Wall, 1965). A person’s memories, cognitions, and 
attention related to their pain can all influence pain signals from the brain. Further, 
Melzack concluded that pain is a complex, multidimensional construct made up of 
affective, cognitive, sensory, and evaluative components, tying the physiological and 




Due to the explosion in pain research following the release of the Gate Control 
Theory, many psychological factors previously thought to be the results of pain were now 
being reassessed as possible causes of pain (Melzack, 2001). The Gate Control Theory 
proposed that the central nervous system is an integral part of the perception of pain, 
therefore, the next part of the puzzle to unravel were the neurological mechanisms 
involved. Melzack (2001) labelled the “neural network, whose spatial distribution and 
synaptic links are initially determined genetically and are later sculpted by sensory inputs, 
a ‘neuromatrix’” (p.1378). Melzack also implicated stress as an implicit mechanism in 
pain, when a person is in pain, they are also experiencing stress which the body seeks to 
moderate in order to return to a state of homeostasis. The Neuromatrix Theory is complex 
and multifaceted, incorporating sensory, cognitive, evaluative, affective, discriminative, 
and stress-regulation systems (Melzack, 2005).  
The Neuromatrix Theory integrated many of the physiological and psychological 
factors that contribute to the perception of pain and is the foundation of the widely 
favoured biopsychosocial model used today (Seth & de Gray, 2019). When thinking about 
chronic pain, it is important to understand that there is a difference between the 
sensations conveyed by nerves (nociception) and the interactions of these sensations 
with the psychological, genetic, social, and cognitive factors which create the subjective 
experience of pain (Seth & de Gray, 2019). It appears that nociception does not always 
create pain nor is it necessary to create the subjective experience of pain, as seen with 
phantom limb pain, when people experience pain where an amputated limb used to be. 
Chronic pain is extremely subjective and individualistic, and it has been found that a 
number of social factors also play a role in its creation and maintenance. A person’s 
current emotional state, mental health status, history of sexual or physical abuse, culture, 
occupation, and alcohol and drug misuse can all contribute to chronic pain (Seth & de 




We now know that the physiology of chronic pain is complex and comprised of 
several different mechanisms (Trachsel & Cascella, 2019). Sensitisation of peripheral 
nociceptors, sensory neurons which respond to possible noxious stimuli by transmitting 
signals to the brain and spinal cord, trigger the activation of central and peripheral 
sensitisation pathways (Dissanayake & Dissanayake, 2016). Peripheral sensitisation is 
caused by changes to the peripheral nerve endings at the site of an injury, whereas 
central sensitisation is enhanced sensitivity in uninjured surrounding areas and is a result 
of changes in the brain and spinal cord (Vardeh & Naranjo, 2017). The spinal dorsal horn 
neurons process the sensory information received from afferent nerves and then transmit 
this information to the central nervous system areas in the brain (Andrew, 2010). When 
acute pain becomes chronic pain there is potentially a pathogenetic change, meaning the 
pain ceases to be merely a sensation and instead could be the origination or development 
of a disease (Nielsen & Henriksson, 2007).  
Our understanding of the complex mechanisms that make up the subjective pain 
experience is now extensive. We know that nociception is not necessary for the sensation 
of pain. We know that pain can persist past the point where it is adaptive and helpful. And 
we know that chronic pain causes significant distress and dysfunction in peoples’ lives. 
Despite all of these advances in understanding the physiological underpinnings of chronic 
pain, there are a number of other factors that can influence the way it is experienced and 
maintained or can improve or worsen it. 
Why is Chronic Pain Difficult to Treat? 
We know that there are a number of variables that can contribute to the formation 
and maintenance of chronic pain, including pain catastrophising, pain intensity, and 
interference. These factors are often used as treatment outcome measures in pain 
management programmes, along with pain self-efficacy, how confident a person is that 
they can do things despite the pain. Furthermore, depression, anxiety, stress, and 




measures (Severeijns et al., 2001). The highly subjective nature of the perception of pain 
is due to the different levels at which a person experiences each of these variables and 
the way the variables interact with each other. By integrating the physiological, 
psychological, and social determinants of chronic pain, clinicians are now able to create 
holistic pain management programmes tailored to the individual’s needs. Despite all of 
these advances there are still no truly effective treatments for chronic pain (Bonica, 1980). 
Currently, many pain management treatment plans, including the QE Health ReCharge 
Programme, attempt to decrease levels of pain catastrophising, pain intensity, and 
interference and increase levels of pain self-efficacy. We know that treatment outcome 
measures are often affected by vulnerabilities such as depression, anxiety, stress, and 
pessimism. However, we also know that there is a growing body of research that 
suggests strengths such as optimism, hope, spirituality, social support, and grit are 
associated with changes in treatment outcome measures. Our research intends to 
determine which vulnerabilities or strengths are associated with the best changes in 
treatment outcome measures. 
Treatment Outcome Measures 
Pain Catastrophising 
Pain catastrophising occurs when a person has an exaggerated negative schema 
regarding pain and their ability to cope with pain (Amtmann et al., 2018; Quartana et al., 
2009; Sullivan et al., 1995). Schemas are the cognitive frameworks we use to organise 
and interpret information, in this case pertaining to the actual or perceived threat of 
experiencing pain. The emotional and cognitive distortions of these schema lead to 
magnification of the pain intensity sensations, a lack of control over pain related thoughts, 
and a sense of helplessness in regard to managing the pain (Schütze et al., 2018). 
Consistent with other factors related to the pain experience, pain catastrophising appears 
to be a complex, multifaceted construct which is associated with higher levels of pain 




Pain catastrophising has been examined for its association with positive (Hood et 
al., 2012; Pulvers & Hood, 2013) and negative (Schütze et al., 2018; Severeijns et al., 
2001) psychological phenomena. People who report higher levels of positive emotions, 
such as hope and optimism, also report lower levels of pain catastrophising (Ong et al., 
2010; Sturgeon & Zautra, 2013). Conversely, people with higher levels of anxiety and 
depression report higher levels of pain catastrophising. Interestingly, a study by 
Severeijns et al. (2001) found that pain catastrophising was a better predictor of pain 
intensity, interference, and psychological distress, than the actual physical impairment. 
The physical aspect of chronic pain appears to be less important than the psychological 
aspect when it comes to predicting pain intensity and interference. We therefore need to 
take other vulnerabilities and possible strengths into account when researching chronic 
pain management. 
Pain Intensity and Interference 
The highly subjective nature of pain intensity, how strong the pain feels, creates 
difficulties when attempting to quantify or measure pain levels (Dansie & Turk, 2013). The 
perceived intensity of sensation can influence a person’s thoughts and emotions about 
what they are capable of doing (Arnstein et al., 1999). Pain interference is conceptualised 
as the degree to which a person’s pain interferes with their functioning in day-to-day life 
(Wilson, 2014). Interestingly, just the fear of increasing pain intensity appears to be 
related to the degree of interference to daily life, the more a person fears their pain 
intensity increasing, the less capable they feel (Costa et al., 2011). In other words, the 
more people believe that their pain causes disability, the more disabled they become 
(Arnstein et al., 1999). If this is the case, then it would appear that attempting to lower a 
person’s level of perceived pain intensity is more suited to a psychological approach than 
a physiological one. Reducing levels of treatment outcome measures such as pain 




There is also a measure that pain management programmes attempt to increase, pain 
self-efficacy. 
Pain Self-efficacy 
Pain self-efficacy refers to a person’s confidence in their ability to perform tasks 
despite their pain (Nicholas, 2007). In chronic pain clients, higher levels of pain self-
efficacy are often associated with lower levels of avoidance behaviours and disability 
(Arnstein, 2000; Arnstein et al., 1999; Asghari & Nicholas, 2001; Costa et al., 2011). Pain 
self-efficacy can mediate the relationship between chronic pain and depression (Arnstein 
et al., 1999) and strongly predicts pain intensity and disability levels (Meredith et al., 
2006).  
A study conducted by Asghari and Nicholas (2001) with 145 chronic pain sufferers 
over a 9-month period demonstrated the importance of pain self-efficacy as a predictor of 
depression, disability, and pain intensity. Interestingly, although the participants were also 
undergoing medical treatment throughout the study, those with low pain self-efficacy 
levels at baseline saw only minimal improvements in comparison to those with high pain 
self-efficacy levels. Therefore, increasing a person’s sense of pain self-efficacy appears to 
be a necessary component for pain management programmes seeking improvements in 
levels of pain catastrophising, pain intensity, and interference. There are also a number of 
vulnerabilities which contribute to these treatment outcome measures, such as 
depression, anxiety, stress, and pessimism. 
Vulnerabilities 
Depression 
When looking at treatment outcome measures, we know that elevated levels of 
depression, anxiety, and stress are common among people living with chronic pain (Bair 
et al., 2008; Tsang et al., 2008). Furthermore, the prevalence of depression in a chronic 




conditions such as arthritis or heart disease (Bair et al., 2008; Banks & Kerns, 1996).  
Banks and Kerns (1996) offer a number of possible reasons for this disparity. Firstly, the 
subjective sensation of pain is extremely aversive, in both its chronic and acute forms. 
One of the defining features of chronic pain is that it is present nearly every day, whereas 
acute pain comes and goes. Thus, even though other medical conditions also experience 
pain it is more likely to be acute and episodic. Another defining feature is that it is pain 
that has lasted for more than six months. Although other medical conditions can also last 
for more than six months, there is normally also a way to treat the condition medically, 
which is not available for chronic pain sufferers. This inability of medical science to offer a 
solution can lead to feelings of hopelessness and despair. This would suggest that it is 
not solely the experience of pain, nor the chronicity of a condition, that leads to higher 
rates of depression. Finally, a person living with chronic pain will often feel that they are 
no longer able to take part in activities that previously brought them pleasure. The fear of 
increasing pain intensity leads to a decrease in activity, which is then reinforced because 
it does not increase pain intensity. By avoiding these activities, the person is not only 
denying themselves the opportunity to disprove this fear as unrealistic, but they are also 
not receiving the positive reinforcement which occurs with pleasurable physical and social 
activities, or with meaningful engagement such as employment. Depression alone can be 
debilitating; however, we know that depression is seldom found in isolation, it is often co-
morbid with anxiety. 
Anxiety 
The combination of chronic pain, depression, and anxiety is correlated with higher 
levels of pain intensity and disability. In a study of 500 chronic pain clients, Bair et al. 
(2008) found that 54% (n=271) of participants reported only chronic pain. Chronic pain 
and anxiety was reported in 3% (n=15) of the sample and chronic pain and depression 
was reported by 20% (n=98). Overall, 23% (n=116) of participants reported both 




person is feeling threatened, whether through the thought of psychological or physical 
danger. Pain related anxiety is more specific to the domains of chronic pain such as fear 
of increased pain, avoidance of activities, and fearful worry about the pain (McCracken & 
Gross, 1998). This anxiety in turn leads to greater focus on the pain itself manifesting as 
increased pain catastrophising, pain intensity, and interference. 
Stress 
Chronic stress and chronic pain appear to activate similar neural pathways, 
specifically the hypothalamo-pituitary-adrenal (HPA) axis (Blackburn‐Munro & Blackburn‐
Munro, 2001). Stressors attached to the experience of chronic pain can include worry 
about long term employment, financial strain, and strain on relationships. These stressors 
then lead to an overactivation of the body’s stress response in the HPA axis. The HPA 
axis is also implicated in the body’s response to painful sensations. Although it is still 
unclear whether there is a causal relationship between stress and pain in the brain’s 
neurology, elevated stress levels are often seen in people living with chronic pain 
(Abdallah & Geha, 2017). More importantly perhaps are the behavioural similarities 
between the two processes, the inability to return the body to a state of homeostasis 
following physical or psychological stress. The focus of much chronic pain research today 
is on whether there are neurological connections between the psychological and 
physiological stress components that are part of the chronic pain experience. 
Neuroscientific research is outside the scope of this paper, but it is an exciting field of 
research that will be worth watching. 
Pessimism 
People who are pessimistic tend to expect bad experiences rather than good ones 
(Schier et al., 1994). The more pessimistic a person is, the higher they rate their pain 
symptoms such as pain intensity and interference (Baker, 2007; Bargiel-Matusiewicz & 
Krzyszkowska, 2009; Robinson-Whelen et al., 1997; Scheier & Carver, 1987). Higher 




levels of pessimism have a tendency to use more dysfunctional modes of coping such as 
denial and distancing. Overall, the literature appears to suggest that optimists and 
pessimists are probably doing things differently to achieve such different pain related 
outcomes (Scheier et al., 1986). 
When looking at pessimism and optimism, lower levels of pessimism is not 
equivalent to higher levels of optimism (Robinson-Whelen et al., 1997). These are two 
related, but separate, constructs. Likewise, decreasing levels of depression is not the 
same as increasing levels of hope. Therefore, we should not only focus on decreasing 
levels of vulnerabilities, but it may also be helpful to focus on increasing levels of 
strengths. There are several strengths that contribute to changes in levels of pain 
catastrophising, pain intensity, interference, and pain self-efficacy. 
Strengths 
Optimism 
Optimism is broadly defined as an overall belief that more good things than bad 
will happen to a person (Scheier & Carver, 1985). More importantly for this study, the 
more optimistic a person is, the lower they subjectively rate their pain intensity, 
interference, and disability levels (Baker, 2007; Bargiel-Matusiewicz & Krzyszkowska, 
2009; Robinson-Whelen et al., 1997; Scheier & Carver, 1987). Moreover, optimism is one 
of the few positive traits that has been shown to reduce experimentally induced pain 
intensity (Geers et al., 2008; Hanssen et al., 2014). Higher levels of optimism are also 
associated with lower levels of stress. 
People with higher levels of optimism appear to use different, more effective, 
coping strategies when it comes to dealing with chronic pain (Scheier & Carver, 1985; 
Scheier et al., 1986). When not facing any health concerns, optimists can be rather blasé 
about health issues. However, when faced with a specific health problem, optimists 




coping strategies, acceptance and resignation, or positive reinterpretation (Scheier et al., 
1986).  
Hope 
Hope and optimism, although both contributing to physical and psychological well-
being, are two separate constructs (Alarcon et al., 2013; Schier et al., 1994). Where 
optimism is a general positive view about one’s future, hope is defined as the cognitive 
process behind a person’s agency “successful determination in meeting past, present, 
and future goals” and pathway “being able to generate successful plans to meet goals” 
(Snyder et al., 1991, p. 570). In relation to chronic pain, people with high levels of hope 
appear to have a higher tolerance for pain and lower reported levels of pain intensity 
(Berg et al., 2008).  
Maintaining high levels of hope while living with chronic pain is often hard due to 
the pervasive nature of chronic pain (Larsen et al., 2015). A meta-analysis of 
psychological interventions for chronic pain found that a person’s attitudes, beliefs, and 
expectations about their pain was one of the most important therapeutic components 
when looking at treatment outcome measures (Hoffman et al., 2007). Thus, increasing a 
person’s levels of hope should have a positive impact on their overall well-being and self-
efficacy while decreasing levels of pain intensity and interference. The goal-oriented focus 
of hope can be construed as an active adaptive strategy, however, hope without action 
can be considered a passive maladaptive strategy similar to prayer (Ashby & Lenhart, 
1994). 
Spirituality 
Spirituality is becoming an important construct for health professionals to consider 
in the provision of mental and physical health care services (Egan et al., 2011). There are 
many different definitions of spirituality, which makes it difficult to synthesise the research. 
Rippentrop et al. (2005) found that many people living with chronic conditions, including 




et al.’s study spirituality was measured with the Brief Multidimensional Measure of 
Religiousness/ Spirituality (BMMRS). This is broken into 11 dimensions; daily spiritual 
experiences, values/beliefs, forgiveness, private religious practices, religious and spiritual 
coping, religious support, religious/spiritual history, commitment, organisational 
religiousness, religious preference, and overall self-ranking     
 Delaney (2005) created The Spirituality Scale, a spirituality/self-awareness scale 
that did not rely on organised religion as a base. Factor analysis left her with three 
subscales; self-discovery, relationships, and eco-awareness. These subscales can be 
used in a practical way in health care to monitor and foster spiritual wellbeing. For 
example, a person with a low score in the self-discovery subscale could be taught some 
simple self-reflection tools such as mindfulness meditation to uncover their existential self 
(Delaney, 2005). The practical and areligious theoretical underpinning of this measure 
make it a potentially useful tool in measuring spirituality in chronic pain clients and it was 
the scale we used in our research. 
There is an interesting contradiction in the literature on the relationship between 
spirituality and chronic pain. There is no clear consensus as to whether spiritual practices 
and beliefs (as measured with the BMMRS) help or hinder people living with chronic pain 
(Rippentrop et al., 2005). A study by Ashby and Lenhart (1994) found that people who 
scored high on use of prayer, as measured with the Coping Strategies Questionnaire, 
also scored high on pain intensity and disability. They suggested that the use of prayer as 
a pain management strategy could be a maladaptive coping mechanism similar to 
avoidance (Ashby & Lenhart, 1994). Naturally these data do not suggest that prayer 
causes physical pain. A possible explanation for these findings could be that as peoples’ 
levels of physical discomfort grows so does the tendency to engage in prayer. It may also 
be that encouraging people living with chronic pain to focus on their self-awareness and 
relationships, with people and the environment, is more adaptive than encouraging 




a church, may provide a source of social support, which is also a topic that may or may 
not be helpful in chronic pain management. 
Social Support 
Social support is another strength with conflicting results as to whether it is helpful 
in the management of chronic pain. López-Martínez et al. (2008) found that social support 
is associated with lower levels of depression and pain intensity, however, they also found 
that higher levels of support and attention from a spouse or intimate partner was 
associated with increased levels of pain behaviours (grimacing, limping) and increased 
levels of pain intensity. A meta-analysis conducted by Che et al. (2018) of 21 studies 
(N=1379) found that interaction with a stranger was associated with lower levels of 
physiological arousal caused by pain, while interaction with an intimate partner or close 
friend was associated with higher levels of physiological arousal. Thus, it is not 
inconceivable that the way in which your spouse or intimate partner communicates with 
you regarding your pain could actually be unintentionally contributing to overall pain 
outcomes. 
On the other hand, broader measures of perceived social support (social 
networks, resources, and support from others) were found to predict lower levels of 
disability and pain intensity at three and five year follow up (Evers et al., 2003). Thus, the 
available literature suggests that social support can be beneficial or detrimental 
depending on the context. Our research was interested in the broader patterns of social 
support and did not ask whether participants had a spouse or intimate partner. Rather, we 
wanted to know whether participants perceived that they were generally well supported in 
their day to day lives, for example, did they have support if they ended up sick in bed. 
Grit 
Grit is defined as perseverance and passion for long-term goals, even in the face 
of adverse life events, and is associated with higher quality of life for chronic pain clients 




occupational performance, however, we have recently seen a shift with new research 
investigating the links between grit and chronic pain (Buckingham & Richardson, 2020; 
Sharkey, 2017; Traino et al., 2019). According to Duckworth et al. (2007), a person with 
grit is more likely to stick to long term plans, despite setbacks and failures. Given some of 
the unique challenges of treating chronic pain it may be helpful to understand how gritty a 
person is. 
 Grit is generally discussed as it relates to a long-term, often highly valued, goal 
such as years spent training on a musical instrument in order to gain a place in an 
orchestra. When applied to chronic pain management the long-term goal may be highly 
valued, for instance lower pain intensity, but not something a person is passionate about 
achieving. A person with higher levels of grit would therefore need to exhibit greater self-
control around necessary, but possibly unpleasant, tasks (such as exercising), despite the 
pain. 
Chronic pain management requires a multi-pronged approach which incorporates 
physical, psychological, and social interventions. Most pain management programmes are 
focused on decreasing levels of treatment outcome measures such as pain 
catastrophising, pain intensity, and interference, while increasing levels of pain self-
efficacy. This goal is often complicated by clients presenting with depression, anxiety, 
stress, and pessimism, which can act as vulnerabilities that may negatively impact their 
treatment outcome measures. However, we know that chronic pain can also be influenced 
by many different strengths. For example, optimism is associated with lower levels of pain 
intensity, interference, and disability (Goodin & Bulls, 2013), while hope is associated with 
higher tolerance for pain, lower pain intensity, and less interference (Snyder et al., 2005). 
Spirituality/self-awareness may be associated with self-discovery, acceptance, and the 
importance of relationships (Delaney, 2005), likewise, social support has been associated 




2003). Finally, grit may play a role in decreasing disability caused by interference 
(Sharkey, 2017). 
What we do not know is which of these vulnerabilities and strengths may have the 
largest effect on treatment outcome measures when we analyse all of them at the same 
time. Which of them may be more salient to focus on when designing individualised 
treatment plans such as the ReCharge Programme? What we still need to research are 
the relationships between treatment outcome measures (pain catastrophising, pain 
intensity, interference, and pain self-efficacy), vulnerabilities (depression, anxiety, stress, 
and pessimism), and strengths (optimism, hope, spirituality, social support, and grit). In an 
attempt to shed some first light onto these important issues, we turn to our research 
questions. 
1. Did the participants see statistically significant changes in the treatment 
outcome measures, vulnerabilities, and strengths during the three-week ReCharge 
Programme from intake to discharge? 
2. Were there any associations between the treatment outcome measures, 
vulnerabilities and strengths? 
3. Did the vulnerability and strength measures have any predictive power on the 
treatment outcome measures?  
4. Were there any long-term effects of the treatment outcome measures at follow-
up? 
 Based on the literature we predicted that participants would see significant 
changes in the treatment outcome measures from intake to discharge and that there 
would be negative correlations between levels of vulnerabilities and pain catastrophising, 
pain intensity and interference and a positive correlation between levels of vulnerabilities 
and pain self-efficacy. Conversely, we predicted that there would be positive correlations 




interference and a negative correlation between levels of strengths and pain self-efficacy. 
We would expect that depression, anxiety, optimism, and hope would have predictive 







Participants experiencing chronic pain were sourced from the QE Health 
ReCharge Programme - a 3-week in-client pain management and rehabilitation 
programme (see Appendix A). All clients who received treatment between the dates of 1st 
January 2020 and 31st November.2020 were invited to take part in this research. 74 
clients (61 female, 13 male) completed the intake survey, however unfortunately, the 
Level 3 and 4 COVID-19 lock down in New Zealand from the 24th of March 2020 to the 14th 
of May 2020 meant that 31 of these participants were unable to complete the ReCharge 
Programme. Of the remaining 43 participants, three returned incomplete data and were 
excluded from the study. This left us with 40 participants (35 women and five men, mean 
age at intake 45.66years, SD = 15.907). Of the 40 participants, only 14 also returned 
surveys at 12-week follow-up (14 women, mean age at intake 44.6 years, SD = 15.520). 
Design 
In a within-subjects design, each participant completed self-report scales when 
they began the ReCharge Programme (Intake). They completed the same self-report 
scales three weeks later when they had completed the programme (Discharge), and 
again at 12-weeks (Follow-up). Our repeated measures was Time: Intake (1), Discharge 
(2), and Follow-up (3). Our dependent variables were self-report measures of:  
Treatment outcome measures: Pain catastrophising, pain intensity, interference, and pain 
self-efficacy. Vulnerabilities: Depression, anxiety, stress, and pessimism. Strengths: 
Optimism, hope, spirituality, social support, and grit. 
Statistical Procedures 
In order to answer the first research question, descriptive statistics (means, 
standard deviations, and 95% confidence intervals) were calculated for Intake, Discharge, 




(Intake vs Discharge), including effect sizes, were then calculated for each dependent 
variable. Associations between dependent variables were then assessed via Pearson’s 
correlations to answer our second research question. Multiple regressions were 
performed to answer our third research question in order to examine how much each 
vulnerability and strength influenced the treatment outcome measures (% of variance 
accounted for). Finally, any long-term effects were assessed in the Follow-up period (12 
weeks after Discharge). Fourteen participants provided full data sets for this part of the 
study (our fourth research question).  
All inferential statistics were calculated using IBM SPSS Statistics 25. When 
treating the data, the decision was made that if an entire scale was missing for a 
participant these data were excluded from the analysis. Missing data was changed to the 
sample mean for the particular scale if there was only one missing data point.   
Ethical Considerations 
Ethics approval for this project was granted by the Human Research Ethics 
Committee (Appendix B) All clients took part in the ReCharge Programme, regardless of 
participation in the research. Clients self-selected themselves (or not) as participants as 
part of the intake procedure on the first day of the ReCharge Programme. Those who 
chose to take part were offered the opportunity to drop out of the study at any time by 
simply not completing the scales. Data collected was anonymised to protect privacy and 
stored on a secure server with password protection.  
Treatment Outcome Measures 
The following scales are those that QE Health require their clients to complete 
before and after taking part in their ReCharge Programme. None of these scales  were 





The Pain Catastrophising Scale (PCS; Appendix D) is a 3-factor tool which 
measures rumination, magnification, and helplessness (Sullivan et al., 1995). Participants 
responded to items about the degree to which they have thoughts and feelings when they 
are experiencing pain on a 5-point Likert scale (0 = not at all to 4 = all the time). Examples 
of the items include “I keep thinking about how  to badly I want the pain to stop” and “I 
wonder whether something serious may happen”. The coefficient alpha for the composite 
PCS scale is .87 (Cronbach, 1951). The PCS composite scores range from 0 – 52 and 
are calculated by summing the responses to the 13 items (Sullivan, 2009). 
Pain Intensity and Interference 
The Brief Pain Inventory for Chronic Non-malignant Pain (BPI; Appendix E) was 
used to evaluate two distinct factors; pain intensity and the degree to which pain interferes 
in everyday activities for people living with chronic pain (Tan et al., 2004). Participants 
responded to each item on an 11-point Likert scale (0 = no pain to 10 = pain as bad as 
you can imagine) about the intensity levels of their pain. There are four categories for the 
pain intensity scale; the worst intensity in the last week, the least intensity in the last 
week, your pain on average, and how much pain do you have right now. The pain 
intensity composite score ranges from 0 – 40 and are calculated by summing the 
responses to the four items. The pain interference scale is designed to measure 
impairment in functioning caused by pain in seven different areas: general activity, mood, 
walking ability, normal work, relations with other people, sleep, and enjoyment of life. This 
is also measured on a Likert scale (0 = does not interfere to 5 = interferes completely). 
The pain interference composite score ranges from 0 – 50 and are calculated by summing 
the responses to the seven items. Factor analysis confirms that the two factors are 
independent and shows acceptable internal consistency for both the intensity (α = .85) 





The Pain Self-Efficacy Questionnaire (PSEQ; Appendix F) is a 10-item measure of 
confidence in one’s ability to complete tasks despite the pain for people experiencing 
ongoing chronic pain, for example “I can enjoy things, despite the pain” (Nicholas, 2007). 
Participants responded to each item on a 7-point Likert scale (0 = not at all confident to 6 
= completely confident6). The PSEQ has excellent internal consistency (α = .92) and 
good test-retest reliability (Tonkin, 2008). PSEQ scores are useful for determining 
clinically significant levels of functioning in chronic pain clients, including predicting risk of 
depression and disability and rehabilitation outcomes. A composite score of 0 - 60 is 
calculated by summing all items. QE Health included the PSEQ in the data they collected, 
therefore, this was not incorporated into the Chronic Pain Wellbeing Scale but measured 
as a separate positive factor. 
Measures of Vulnerabilities 
Depression, Anxiety, and Stress 
The Depression Anxiety Stress Scale – 21 ( DASS-21; Appendix G) is a set of 
three self-report scales consisting of seven items each (Lovibond, 1995). Examples of the 
items include depression “I found it difficult to work up the initiative to do things”, anxiety “I 
was aware of dryness of my mouth”, and stress  “I felt that I was using a lot of nervous 
energy”. Participants responded to each item on a 4-point Likert scale, (0 = did not apply 
to me at all to 3 = applied to me very much or most of the time). The DASS-21 has been 
shown to have adequate construct validity and high reliability (α = <.70) for all the 
subscales according to Nunnally (1994); depression (α = .88), anxiety (α = .82), and 
stress (α = .90) (Cronbach, 1951). It also displays sufficient discrimination between the 
three scales (Henry & Crawford, 2005). The DASS-21 has good convergent and 
discriminant validity when compared with other measures of anxiety, depression, and 
stress. The DASS-21 composite scores range from 0 – 21 and are calculated by summing 





Pessimism was measured using The Life Orientation Test Revised (LOT-R; 
Appendix H), which also measures optimism. Although related, pessimism is not merely 
the opposite of optimism, it is a separate construct and is explained below (see 
Optimism).  
Measures of Strengths 
Strengths were measured with the Chronic Pain Wellbeing Scale (Appendix M), a 
scale created by merging well validated measures for optimism and pessimism, hope, 
spirituality, social support, and grit. These scales were merged at the request of QE 
Health for ease of use and brevity as participants are already required to complete pages 
of paperwork. In order to make the form as simple as possible the same responses were 
listed for all questions. The responses for all scales were changed to a 5-point Likert scale 
(1 = very much like me to 5 = not like me at all). These responses were identified as being 
suitable for all questions in the Chronic Pain Wellbeing Scale after peer review. The 
following five scales were incorporated into the Chronic Pain Wellbeing Scale 
Optimism 
The Life Orientation Test Revised (LOT-R; Appendix H), is a 10-item measure of 
optimism “In uncertain times, I usually expect the best”, and pessimism “If something can 
go wrong for me, it will” (Schier et al., 1994). Of the 10 items, the three items measuring 
pessimism and the three items measuring optimism were used. Four items used as fillers 
intended to disguise the purpose of the scale were not included in the Chronic Pain 
Wellbeing Scale (Goodin & Bulls, 2013). Responses were changed from a 5-point Likert 
scale (A = I agree a lot to E = I disagree a lot) to a 5-point Likert scale (1 = not much like 
me to 5 = very much like me). The test-retest reliability for the LOT-R and concurrent 
validity has been established, as has the internal validity (α = .78) (Schier et al., 1994). A 




10. A composite score (0 – 15) for the pessimism scale is calculated by summing items 3, 
7, and 9. 
Hope 
The Adult Trait Hope Scale (ATHS; Appendix I), is made up of 10 items 
comprising two subscales; pathway “I can think of many ways to get the things in life that 
are important to me.” and agency “I’ve been pretty successful in life.” (Snyder et al., 
1991). Six items were used from the ATHS, four questions described by the scale’s 
creator as “fillers” which do not contribute to the overall score were not used in the 
Chronic Pain Wellbeing Scale (Babyak et al., 1993). Responses were changed from an 8-
point Likert scale (1 = definitely false to 8 = definitely true) to a 5-point Likert scale (1 = not 
much like me to 5 = very much like me). The Adult Trait Hope Scale has acceptable 
internal reliability (Cronbach’s α = .70 to .80), demonstrates convergent and discriminant 
validity, and has test-retest coefficients ranging from .70 to .80 (Babyak et al., 1993). 
Scores are calculated by summing items 1, 2,4, 6, 8, 9, 10, and 12 giving a composite 
Hope Scale score ranging from 0 – 40. 
Spirituality 
The Spirituality Scale (SS; Appendix J) is a 23-item scale designed to measure 
intuitions, beliefs, lifestyle choices, rituals, and practices related to spirituality (Delaney, 
2005). The SS has high internal consistency (α = .94) with the three subscales ranging 
from .81 to .94. For the sake of brevity, the original scale was cut to 10 questions based 
on the factor analysis for each subscale. Examples of the remaining items include “I have 
a sense of purpose” and “I am able to receive love from others”. Responses were 
changed from a 6-point Likert scale (1 = strongly disagree to 6 = strongly agree) to a 5-
point Likert scale (1 = very much like me to 5 = not like me at all). Scores were calculated 





The Duke-UNC Functional Social Support Questionnaire (FSSQ; Appendix K) was 
designed to measure the functional social support people perceived that they received in 
life (Broadhead et al., 1988). Example questions include “I get a chance to talk to 
someone I trust about my personal or family problems“ and “I have people who care what 
happens to me”. Responses were changed from an 8-item Likert scale (1 = much less 
than I would like to 5 = as much as I would like) to a 5-item Likert scale (1 = very much 
like me to 5 = not like me at all). All eight questions from the FSSQ were used in the 
Chronic Pain Wellbeing Scale. The FSSQ displays very good discrimination for each of 
the scales, with item-total correlation scores of.62 for confident support and .64 for 
affective support (Broadhead et al., 1988). A composite score (0 – 40) is calculated by 
summing all items. 
Grit 
All items in The Short Grit Scale (GRIT-S; Appendix L) were used. GRIT-S is an 8-
item Likert scale (1 = very much like me to 5 = not like me at all) measuring trait 
perseverance and a person’s passion for achieving long-term goals (Duckworth & Quinn, 
2009). Items are split between two subscales; consistency of interest “New ideas and 
projects sometimes distract me from previous ones” and perseverance of interest “I finish 
whatever I begin”. The GRIT-S displays acceptable internal consistency (α = .73 to .83). 
The GRIT-S has been shown to be relatively stable over time with good test-retest 
reliability (Duckworth & Quinn, 2009). A composite score (0 – 40) is calculated by 
summing all items. 
Procedure 
All clients attending the QE Health ReCharge Programme were given the 
opportunity to take part in this research project. Those who chose to participate were 
given the Chronic Pain Wellbeing Scale to complete along with the scales to be 




time points: day of admission to the ReCharge Programme, day of discharge from 
ReCharge Programme after three weeks, and 12-week follow-up. There was no face-to-
face interaction between potential participants and the researcher, and all scales were 
self-report measures. Contact with participants was initiated by the ReCharge Programme 
staff and all participants signed a consent and information form (Appendix C). The only 





Results and Discussion 
Research Question 1 
Our first research question was: Did the participants see statistically significant 
changes in the treatment outcome measures, vulnerabilities, and strengths during the 
three-week ReCharge Programme from intake to discharge?   
Results 
In order to answer this question, we first calculated the mean and variability scores 
for all variables at intake and at discharge three weeks later (see Table 1 for descriptive 
statistics). We then created box plots depicting means (horizontal line within the boxes 
and 25% and 75% percentiles, lower and upper boundaries and with 95% confidence 
intervals (error bars) for treatment outcome measures, pain catastrophising, pain 
intensity, and interference (Figure 1), pain self-efficacy (Figure 2), vulnerabilities, 
depression, anxiety, stress, and pessimism (Figure 3), and strengths, optimism, hope, 
spirituality, social support and grit (Figure 4).  
We checked that we met the assumptions for paired samples t-tests. Firstly, our 
dependent variable (time) was a continuous variable, and secondly, our independent 
variables consisted of two or more categories (intake, discharge, and follow-up). 
However, there were some outliers as assessed by boxplot which were modified to the 
largest or smallest data value that was not an outlier. Once the outliers had been 
modified, we determined that the data was normally distributed as assessed by the 
Shapiro-Wilk’s test (p>.05). The assumption of normality was not met for pain 
catastrophising or pain intensity as assessed by the Shapiro-Wilk’s test (p = .018 and p = 
.038 respectively). As the paired samples t-test is considered to be relatively robust when 
it comes to violations of normality the decision was made to run the analyses anyway 






Boxplots for Mean Treatment Outcome Measures (Intake and Discharge) 




Note: N = 40. Box plots indicating mean scores, 25% and 75% percentiles for the 
outcome measures pain catastrophising, pain intensity, and interference at intake and 
discharge. * = p<.05, ** = p<.01. The error bars indicate 95% confidence intervals. 
 
As we can see in Figure 1, the biggest change was in levels of interference, 
followed by pain catastrophising and then intensity. As the p value for all three pairs was 
less than .000, we decided there was no need to run a Bonferroni post hoc calculation for 
the treatment outcome measures. 
Participants saw a highly significant decrease in pain catastrophising from intake 
to discharge (t(39) = 5.827, p < .000, d = .921, large effect size). They also saw a highly 
significant decrease in pain intensity (t(39) = 7.292, p <.000, d = 1.153, large effect size) 
and in interference (t(39) = 9.945, p <.000, d = 1.573, large effect size). 
**





Figure 2 shows that participants’ levels of pain self-efficacy increased from intake 
to discharge. Inferential statistics (paired samples t-tests) confirmed that the differences in 
levels of all treatment outcome measures, including pain self-efficacy, from intake to 
discharge were statistically highly significant.  
Participants saw an increase in pain self-efficacy from intake to discharge (t(39) = 









Note: N = 40. Box plots indicating mean scores, 25% and 75% percentiles for the 
outcome measure pain self-efficacy at intake and discharge. * = p<.05, ** = p<.01. The 





Figure 3 shows that participants saw a change in depression from intake to 
discharge (t(39) = 7.411, p < .000, d = 1.172, large effect size). There was also a change 
in anxiety from intake (t(39) = 5.095, p < .000, d = .806), stress (t(39) = 6.079, p < .000, d 
= .0961, large effect size), and pessimism (t(39) = 4.654, p < .000, d = .736, large effect 
size). In other words, participants experienced decreases in all of the vulnerability 
measures.  
Figure 3 










Note: N = 40. Box plots indicating mean scores, 25% and 75% percentiles for depression, 
anxiety, stress, and pessimism at intake and discharge. * = p<.05, ** = p<.01. The error 




















Note: N = 40. Box plots indicating mean scores, 25% and 75% percentiles for optimism, 
hope, spirituality, social support, and grit at intake and discharge. * = p<.05, ** = p<.01. 
The error bars indicate 95% confidence intervals. 
 
Figure 4 shows that participants’ levels of optimism, hope, spirituality, social 
support, and grit all increased from intake to discharge. We adjusted for Bonferroni 
correction by dividing the alpha level of .05 by the five t-tests performed. This calculation 







strengths. Inferential statistics (related t-tests) confirmed that the differences in levels of 
hope, social support, and grit statistically significant. Changes in levels of optimism and 
spirituality were not statistically significant. 
Participants saw a change in levels of hope from intake to discharge (t(39) = -
2.973, p < 0.01, d = -.470) in social support (t(39) = -4.406, p < 0.01, d = -.697), and in grit 
(t(39) = -2.73, p < 0.01, d = -.432). There was a change in levels of optimism from intake 
to discharge (t(39) = -1.794, p > 0.05, d = .284) and spirituality (t(39) = -2.366, p > 0.05, d 







Means and Standard Deviations for Treatment Outcome Measures, Pain Self-efficacy, Vulnerabilities, and Strengths (Intake and Discharge) 
 Intake Discharge 95% CI   Cohen’s 
Variable M SD M SD LL, UL t p d 
Treatment Outcome Measures         
Pain catastrophising 24.725 14.301 12.752 9.506 16.165, 5.827 5.827 <.000 .921 
Pain intensity 22.475 5.444 16.450 4.961 4.354, 7.696 7.292 <.000 1.153 
Interference 46.975 11.506 24.650 11.725 17.785, 26.865 9.945 <.000 1.573 
Pain Self-efficacy 24.525 11.449 39.525 11.589 -18.746, -11.251 -8.094 <.000 1.280 
Vulnerabilities         
Depression 8.800 5.336 2.300 1.977 4.726, 8274 7.411 <000 1.172 
Anxiety 6.325 4.072 3.150 1.902 1.915, 4.435 5.095 <000 .806 
Stress 10.425 5.879 5.175 3.594 3.503, 6.997 6.079 <.000 .096 
Pessimism 9.125 3.014 7.175 3.003 1.102, 2.798 4.654 <.000 .736 
Strengths         
Optimism 9.075 2.474 9.700 2.103 -1.330, .070 -1.794 .081 .284 
Hope 26.665 5.056 29.050 6.627 -3.991, -.759 -2.973 .005 -.470 
Spirituality 37.850 6.724 39.880 7.852 -3.617, -.283 -2.366 .023 -.607 
Social support 27.975 7.427 31.350 6.908 -4.924, 4.627 -4.406 <.000 -.697 
Grit 26.325 4.627 28.075 4.958 -3.045, -.455 -2.73 .009 -.432 




Pain management programmes want to see changes in levels of treatment 
outcome measures - pain catastrophising, pain intensity, interference, and pain self-
efficacy. Results from participants who took part in the ReCharge Programme clearly 
demonstrate that clients saw statistically significant changes in all of these measures from 
intake to discharge (Table 1). Our analyses found that the highest level of change was for 
interference, followed by pain self-efficacy, pain catastrophising, and pain intensity. 
Interference refers to how often a person’s pain interferes with their daily life, while pain 
self-efficacy refers to how confident a person is that they can manage their daily life 
despite the pain.  
We were expecting to find that pain self-efficacy was the variable with the greatest 
level of change given the current research, which highlights the association between pain 
self-efficacy, all the other treatment outcome measures, all the vulnerabilities, and all the 
strengths. The fact that interference saw a greater level of change may be due to the 
wording of the scales. The scale for interference asks, “During the past week, how much 
has pain interfered with the following?” (Jensen & McFarland, 1993). The pain self-
efficacy scale is worded, “Remember, this questionnaire is not asking whether or not you 
have been doing these things, but rather how confident you are that you can do them at 
present despite the pain” (Nicholas, 2007). This may appear to be merely semantics, but 
there is also a possibility that participants were not letting the pain interfere as much as 
they normally would ‘during the past week’ while taking part in the ReCharge Programme.  
The ReCharge Programme is a three-week inpatient programme where 
participants are given a weekly timetable from Monday to Friday, beginning at 7.00am 
and finishing at 5.00pm. The expectation that participants could and would complete 
these daily tasks may have motivated people to push themselves to do things they would 
not have attempted otherwise. It is interesting though that this increase in actual ability to 




complete tasks. People living with chronic pain often face a multitude of other hurdles in 
daily life such as a low income, lack of support, social isolation, and limited access to 
facilities such as gyms and hydrotherapy pools. While in the ReCharge Programme these 
hurdles disappear, so it may be that people are less confident that they can continue with 
these tasks once they go back home. 
Participants also saw statistically significant changes in depression, stress, 
anxiety, and pessimism, respectively. The ReCharge Programme includes interventions 
aimed at reducing levels of these vulnerabilities, therefore, we would expect to see these 
changes. The scores from the scales completed at discharge may be positively skewed, 
in that on their final day of the programme participants could be buoyed up by the 
previous three weeks achievements and feeling more hopeful about the future. It would 
be interesting to be able to determine if these levels held over the 12-week follow-up 
period, however, we did not have the number of participants necessary to make that 
analysis. 
Among the strengths, there were statistically significant differences in social 
support, hope, and grit, not in optimism or spirituality. Unlike the treatment outcome 
measures and vulnerabilities, most of these strengths are not explicitly targeted by the 
ReCharge Programme. The  fact that significant changes still occurred would suggest that 
introducing interventions aimed at increasing levels of strengths could help to improve 
treatment outcome measures and levels of vulnerabilities. Based on the literature, we 
were expecting to see some level of change in optimism, especially given the changes in 
levels of all treatment outcome measures. Optimism is associated with all treatment 
outcome measures, vulnerabilities, and strengths. Therefore, we would expect that 
changes in levels of any other variable could potentially lead to a change in levels of 
optimism.  
Hope is the one strength that is currently included in the ReCharge Programme, 




defined of as pathway (being able to see a path towards achieving ones’ goals) and 
agency (one’s ability to navigate that pathway) (Snyder et al., 1991). Over the course of 
the ReCharge Programme participants not only learn how to frame their goals, but they 
are also being positively reinforced for achieving their goals within the programme. The 
skills learnt in the programme also include flexibility, the ability to recognise if a plan is not 
working as intended and devise a new, more achievable, course of action.  
Overall, it appears that the ReCharge Programme was successful in significantly 
reducing levels of pain catastrophising, pain intensity, interference, depression, anxiety, 
stress, and pessimism for our 40 participants. It also significantly increased levels of pain 
self-efficacy, hope, social support, and grit. The increases in levels of strengths are 
currently occurring without targeted interventions, therefore, it is possible that working to 
increase levels of strengths could further contribute to the positive changes in all areas of 
a participants’ chronic pain management. 
Research Question 2 
Our second research question was: Were there any associations between the 
treatment outcome measures, vulnerabilities and strengths? 
Results 
We calculated Pearson’s correlations in order to determine whether the 
associations between treatment outcome measures, vulnerabilities, and strengths were 
significant, (see Table 2 for descriptive statistics). The only variables that were not 
significantly correlated with treatment outcome measures were anxiety and social support. 
All correlations met the assumptions of normality, as assessed by the Shapiro-Wilk’s test  
(p>.05).  
As participant’s levels of depression, stress, and pessimism increased, their levels 
of pain catastrophising, pain intensity, and interference also increased. As participants’ 




catastrophising and interference decreased. As levels of optimism increased, levels of 
pain intensity decreased. 
As shown in Figure 5, there was a strong positive correlation between levels of 
pain catastrophising and depression, r(38) = .742, p <.01, R2 = .550. Figure 6 shows there 
was a strong negative correlation between levels of pain catastrophising and hope, r(38) = 
-.549, p <.01, R2 = .309. In other words, people with higher levels of depression had 






Scatterplot for Mean Pain Catastrophising and Mean Depression (Intake and Discharge) 
  
 
Note: N = 40. Scatter plot for Pearson’s correlations of mean pain catastrophising (intake 










Note: N = 40. Scatter plot for Pearson’s correlations of mean pain catastrophising (intake 





























































































































Treatment outcome measures            
Pain intensity .457**            
Interference .609** .471**           
Pain self-efficacy -.417** -.170 -.452**          
Vulnerabilities             
Depression .742** .187 .508** -.346*         
Anxiety .243 .001 .172 -.257 .401**        
Stress .583** .237 .533** -.417** .707** .611**       
Pessimism .589** .424** .406** -.348* .517** .304* .412**      
Strengths             
Optimism -.521** -.325* -.359* -.344* -.583* -.273* -.448** -.686**     
Hope -.549** -.252 -.367** -.606** -.501** -.370** -.492** -.581** .535**    
Spirituality -.487** -.127 -.421** -.459** -.542** -.340* -.497** -.608** .673** .724**   
Social support -.150 .103 -.083 -.192 -.266* .069 -.305* -.291* .526** .272* .536**  
Grit -.440** -.079 -.189 -.572** -.410** -.227 -.315* -.220 .318* .614** .383** .138 
Note: This table shows the correlation of mean (intake and discharge) scores for all treatment outcome measures, vulnerabilities, and 




We were also interested in analysing the relationships between overall totals of 
vulnerabilities, and strengths correlate with levels of pain catastrophising, pain intensity, 
and interference, and pain self-efficacy.  
We calculated the total score for each scale measuring treatment outcome 
measures (pain catastrophising, pain intensity, interference), pain self-efficacy, 
vulnerabilities (depression, anxiety, stress, pessimism), and strengths (optimism, hope, 
spirituality, social support, grit) from each participants intake and discharge scales. We 
then calculated the mean total scores for each scale (see Table 3). All relationships 
reported are linear and have met the assumption of normal distribution (Shapiro-Wilk’s 
test p>.05). 
We then calculated correlations between levels of mean treatment outcome 
measures (including pain self-efficacy), vulnerabilities, and strengths (see Table 2 for 
descriptive statistics). As all of the treatment outcome measures, vulnerabilities, and 
strengths are significantly correlated we next transformed the scores to standardised z-
scores as the scales were all measured differently. Finally, we created composite scores 
for mean treatment outcome measures (including pain self-efficacy), mean vulnerabilities, 












Mean Levels of Treatment Outcome Measures, Pain Self-efficacy, Vulnerabilities, and 
Strengths 
Variable M 95% CI SD N 
  LL, UL   
Treatment outcome measures     
Pain catastrophising 18.95 15.68, 22.22 10.215 40 
Pain intensity 19.78 18.34, 21.21 4.481 40 
Interference 36.00 33.06, 38.94 9.193 40 
Pain self-efficacy 32.25 29.08, 35.42 9.907 40 
Vulnerabilities     
Depression 5.83 4.94, 6.74 2.845 40 
Anxiety 5.00 4.20, 5.80 2.512 40 
Stress 8.03 6.73, 9.32 4.060 40 
Pessimism 8.43 7.56, 9.29 2.697 40 
Strengths     
Optimism 9.58 8.93, 10.22 2.024 40 
Hope 28.03 26.32, 29.73 5.337 40 
Spirituality 39.08 36.90, 41.25 6.814 40 
Social support 29.85 27.69, 32.01 6.739 40 
Grit 27.48 26.10, 28.85 4.291 40 







Pearson's Correlations for Mean Composite Treatment Outcome Measures, Pain Self-








-.456**   
Composite 
Vulnerabilities 
.655** -.440**  
Composite 
Strengths 
-.461** .560** -.632** 
Note: This table shows the Pearson’s correlations for the mean composite z-scores for 
treatment outcome measures, pain self-efficacy, vulnerabilities, and strengths. ** 




There was a statistically significant positive correlation between mean composite 
treatment outcome measures and mean composite vulnerabilities, r(38) = .655, p <.01, R2 
= .429. Participants with higher mean total vulnerabilities had higher levels of mean 
treatment outcome measures (Figure 7). The positive nature of this correlation means that 
as participants’ levels of vulnerabilities increase their levels of treatment outcome 











Note: N = 40. Scatter plot for Pearson’s correlations of mean composite vulnerabilities z-
scores (intake and discharge) and mean composite treatment outcome measures z-










Note: N = 40. Scatter plot for Pearson’s correlations of mean composite strengths z-
scores (intake and discharge) and mean composite treatment outcome measures z-
scores (intake and discharge), including 95% confidence intervals. 
 
There was a statistically significant negative correlation between mean composite 
treatment outcome measures and mean composite strengths, r(38) = -.614, p <.01, R2 = 
.213. Participants with higher levels of mean composite strengths had lower levels of 
mean composite treatment outcome measures (Figure 8). This correlation is negative, 
meaning that as participants’ levels of strengths increased, their levels of treatment 








Scatterplot for Pain Self-efficacy and Composite Vulnerabilities (Intake and Discharge) 
 
 
Note: N = 40. Scatter plot for Pearson’s correlations of mean self-efficacy z-scores (intake 
and discharge) and mean composite vulnerabilities z-scores (intake and discharge), 
including 95% confidence intervals. 
 
There was a statistically significant negative correlation between mean pain self-
efficacy and mean composite vulnerabilities, r(38) =-.440, p <.01, R2 = .194. Participants 
with higher levels of mean pain self-efficacy had lower levels of mean composite 
vulnerabilities (Figure 9). This correlation is negative, meaning that as participants’ levels 










Scatterplot for Pain Self-efficacy and Composite Strengths (Intake and Discharge) 
 
 
Note: N = 40. Scatter plot for Pearson’s correlations of mean pain self-efficacy z-scores 
(intake and discharge) and mean composite strengths z-scores (intake and discharge), 
including 95% confidence intervals. 
 
There was a statistically significant positive correlation between mean pain self-
efficacy and mean composite strengths, r(38) = .560, p <.01, R2 = .314. Participants with 
higher levels of mean pain self-efficacy had higher levels of mean composite strengths 
(Figure 10). This correlation is positive, meaning that as participants’ levels of pain self-
efficacy increased, so did their levels of composite strengths. 
There was a statistically significant negative correlation between mean total 
vulnerabilities and mean total signature strengths, r(38) = -.632, p <.01, R2 = .399. 
Participants who had higher levels of mean total vulnerabilities had lower mean levels of 







Scatterplot for Composite Vulnerabilities and Composite Strengths (Intake and Discharge) 
 
 
Note: N = 40. Scatter plot for Pearson’s correlations of mean composite vulnerabilities z-
scores (intake and discharge) and mean composite strengths z-scores (intake and 
discharge), including 95% confidence intervals. 
 
Discussion 
Overall, having lower levels of depression, stress, and pessimism, and higher 
levels of optimism, hope, spirituality, and grit were correlated with improvements in 
treatment outcome measures during the ReCharge Programme.  
Participants with higher levels of pain catastrophising had higher levels of 
depression, stress, and pessimism, with depression accounting for 55% of the variance in 
pain catastrophising (Figure 5). Rumination and feelings of helplessness are key 
components in depression; therefore, we would expect to see a relationship between 
changes in pain catastrophising and depression. This high level of depression is in line 




chronic pain populations, and higher rates of chronic pain in populations with depression, 
than in the general population. In our study, higher levels of depression were also 
significantly associated with lower levels of optimism, hope, spirituality, social support, 
and grit. 
Interestingly, we did not find a correlation between pain catastrophising and 
anxiety. As anxiety is often comorbid with depression, we were expecting to see that 
mean anxiety levels were similar to mean levels of depression. Participants who had 
higher levels of pain intensity had higher levels of pessimism, while people who had 
higher levels of interference also had higher levels of depression, stress, and pessimism. 
Participants with higher mean levels of optimism, hope, spirituality, grit, and pain 
self-efficacy had lower mean levels of pain catastrophising, with hope accounting for 
30.9% of the variance in pain catastrophising (Figure 6). We did not find any correlations 
between pain intensity and hope, spirituality, social support, grit, and pain self-efficacy. 
We did find that participants with lower levels of pain intensity had higher levels of 
optimism, which we were expecting to see. We did not find any correlations between pain 
interference and social support or grit. 
Research Question 3 
Our third research question was : Did the vulnerability and strength measures 
have any predictive power on the treatment outcome measures?  
Results 
In order to answer this question, we attempted to calculate several hierarchical 
multiple regressions. We used the change (from intake to discharge) of the composite 
scores of the first outcome measures (pain catastrophising, pain intensity, interference), 
as well as the second outcome measure (ain self-efficacy), as dependent variables and 
the composite score of the vulnerability measures (anxiety, depression, stress, 
pessimism) and the composite score of the strength measures (optimism, hope, 




From the outset we were aware that our small sample size (N=40) would give us 
very little statistical power for generating significant regression models. Nevertheless, one 
model, entering the composite score of the vulnerability measures as the predictor into 
the regression with one of the outcome (dependent) measure (composite score of pain 
catastrophising, pain intensity, and interference) returned a significant effect (see Table 
5). The vulnerability measures (composite score) were accounting for almost 25% (see R 
Squares) of the changes in the dependent variable from intake to discharge (R2 = .245, 
F(1, 39) = 12.354 p<0.01). All other models were not significant. This means that the 
changes (decreased levels) in depression, anxiety, stress, and pessimism were so strong 
that they significantly and positively influenced the treatment outcomes, even in a sample 








Results for Multiple Regression Model 1 















1 .495a .245 .225 7.14741 .245 12.354 1  
Note: This table presents the results of a hierarchical multiple regression for the 
composite score of pain catastrophising, pain intensity, and interference. a. Predictor: 





Despite working with very little statistical power, one model of the conducted 
multiple regressions was significant. The vulnerability measures (depression, anxiety, 
stress, and pessimism) seem to influence the outcome measures (pain catastrophising, 
pain intensity, and interference) to a very large extent and it is therefore recommended to 
continue addressing the vulnerabilities of participants during the ReCharge Programme. 
In order to assess appropriately the effect of the vulnerability and strength variables as 
predictors on the changes of pain self-efficacy via multiple regression we would need to 
recruit a larger sample of participants. Likewise, the effects of the strength predictor 
variables on the dependent composite score of pain catastrophising, pain intensity, and 
interference needs to be assessed in a larger sample. 
Research Question 4 
Our final research question was: Were there any long-term effects of the treatment 
outcome measures at follow-up?  
Results 
In order to answer this question, we followed the same procedure we used to 
answer our first research question. We first calculated the mean and variability scores for 
all variables at discharge and at 12-week follow-up (see Table 4 for descriptive statistics). 
We then created box plots depicting means (horizontal line within the boxes and 25% and 
75% percentiles, lower and upper boundaries and with 95% confidence intervals (error 
bars) for treatment outcome measures (Figure 7), pain self-efficacy (Figure 8), 
vulnerabilities (Figure 9), and strengths (Figure 10).  
Inferential statistics (paired samples t-tests) confirmed that the differences in 
levels of all treatment outcome measures, including pain self-efficacy, from discharge to 
follow-up were not statistically significant. Given the small sample size it is not surprising 
that we did not find any statistically significant changes. Although there were a number of 




with values from the full participant pool (N=14) for intake and discharge and were left in 
the analyses. 
As we can see in Figure 12, participants saw a decrease in pain catastrophising 
from discharge to follow-up (t(13) = 2.005, p = .066, d = .890). However, participants saw 
an increase in pain intensity (t(13) = -.477, p =.641, d = 1.347) and in interference (t(13) = 
-1.781, p =.098, d = 1.501). 
In other words, participants’ levels of pain catastrophising decreased, however, 
mean levels of interference increased, while pain intensity also increased slightly during 




Boxplots for Mean Treatment Outcome Measures (Discharge and Follow-up) 
 
Note: N = 14. Box plots indicating mean scores, 25% and 75% percentiles for pain 
catastrophising, pain intensity, and interference at discharge and 12-week follow-up. The 





Boxplots for Mean Pain Self-efficacy (Discharge and Follow-up) 
 
 
Note: N = 14. Box plots indicating mean scores, 25% and 75% percentiles for the 
outcome measure pain self-efficacy at discharge and 12-week follow-up. The error bars 
indicate 95% confidence intervals. 
 
As we can see in Figure 13, participants saw a very slight decrease in pain self-
efficacy from discharge to follow-up (t(13) = .326, p = .749, d =-1.646).  
The mean score for levels of pain self-efficacy stayed relatively stable between 











Boxplots for Mean Vulnerabilities (Discharge and Follow-up) 
 
Note: N = 14. Box plots indicating mean scores, 25% and 75% percentiles for depression, 
anxiety, stress, and pessimism at discharge and 12-week follow-up. The error bars 
indicate 95% confidence intervals. 
 
When we ran paired sample t-tests for the vulnerabilities we adjusted for 
Bonferroni correction by dividing the alpha level of .05 by the four t-tests performed. This 
calculation meant that the significance level alpha was changed from p < .05 to p <.0125 
for all vulnerabilities.  
As we can see in Figure 14, stress was the only vulnerability that showed a 
statistically significant difference from discharge to follow up, (t(13) = -3.218, p =.007, d = 
.920), however, this was an increase in levels of stress, not a decrease. Participants also 
saw increases in levels of depression (t(13) = -2.047, p = .061, d = 1.060), anxiety (t(13) = 
-1.429, p =.177, d = 0.751), and pessimism  (t(13) = -1.716, p =.110, d = 0.998), none of 





Boxplots for Mean Strengths (Discharge and Follow-up) 
 
 
Note: N = 14. Box plots indicating mean scores, 25% and 75% percentiles for optimism, 
hope, spirituality, social support, and grit at discharge and 12-week follow-up. The error 
bars indicate 95% confidence intervals. 
 
As we can see in Figure 15, levels of grit increased from discharge to follow up, 
(t(13) = -2.321, p =.037, d =-.884). Levels of optimism (t(13) = -.530, p =.605, d = .554) 
and hope (t(13) = .358, p =.726, d = -.734) stayed relatively stable, while levels of 
spirituality (t(13) = 2.498 p =.027, d = -.778) and social support (t(13) = 1.939, p =.074, d 
= -.594) decreased. 
In other words, levels of grit increased from discharge to follow up, while levels of 
hope and optimism were largely maintained after discharge. Levels of social support and 
spirituality decreased between discharge and 12-week follow-up. None of these changes 




Means and Standard Deviations for Treatment Outcome Measures, Pain Self-efficacy, Vulnerabilities, and Strengths at Discharge and Follow-
up 
 Discharge Follow-up 95% CI   Cohen’s 
Variable M SD M SD LL, UL t p d 
Treatment Outcome Measures         
Pain catastrophising 12.429 11.022 7.214 8.728 -.403, 10.831 2.005 .066 .890 
Pain intensity 15.571 4.910 16.357 5.528 -4.346, 2.775 -.477 .641 1.347 
Interference 23.286 11.317 30.429 15.027 -15.808, 1.522 -1.781 .098 1.501 
Pain Self-efficacy 41.714 11.418 41.214 9.673 -2.811, 3.811 .326 .749 -1.646 
Vulnerabilities         
Depression 2.286 2.268 4.623 3.962 -4.844, .130 -2.047 .061 1.060 
Anxiety 3.714 1.816 5.500 3.995 -4.486, .915 -1.429 .177 0.751 
Stress 4.786 3.093 7.571 4.972 -4.656, -.916 -3.218 .007 .920 
Pessimism 6.286 2.920 7.357 2.920 -2.420, .277 -1.716 .110 0.998 
Strengths         
Optimism 10.357 1.823 10.643 2.499 -1.450, .879 -.530 .605 .554 
Hope 31.143 5.260 30.643 5.429 -2.519, 3.519 .358 .726 -.734 
Spirituality 42.071 6.878 39.629 5.744 .694, 9.591 2.498 .027 -.778 
Social support 32.357 6.160 28.429 8.618 -.448, 8.305 1.939 .074 -.594 
Grit 28.786 4.526 33.500 9.338 -9.102, -.326 -2.321 .037 -.884 





 Ideally, skills learned, and gains made during a pain management programme 
would be maintained after the programme finishes. Participants who are able to 
generalise the things they learn in a programme to their everyday life are more likely to 
maintain those changes.  
 Although we did not have enough participants (N=14) to make meaningful 
analyses, the data we did receive was not promising. It is important to note that the 
participants who did return the follow-up scales may not be representative of the entire 
sample for this study, which in turn may not be representative of the entire population of 
New Zealanders living with chronic pain. Out of all the variables that we measured, only 
pain catastrophising and grit showed improvements in levels from discharge to follow-up. 
Levels of pain self-efficacy, hope, and optimism appeared to be maintained during this 
period, however, levels of the pain intensity and interference treatment outcome 
measures worsened. All of the vulnerabilities worsened, with increased levels of stress, 
depression, anxiety, and pessimism, respectively. In the strengths, levels of social support 
and spirituality also worsened. 
 Decreases in levels of pain catastrophising alongside increases in levels of 
depression is an interesting pairing as the two share some similar constructs. We would 
expect that improvements in one of these variables would also lead to improvements of 
the other. One possible explanation could be that the ReCharge Programme has shifted 
participants maladaptive thoughts and beliefs regarding their pain to a more adaptive 
level, which participants have continued to challenge after discharge from the programme. 
At the same time, participants may also have experienced a post-programme slump as 
the access to services and staff available during the programme disappear. It has also 
been shown that for many people who seek help for psychological distress, the mere fact 




(McCarney et al., 2007). Once that attention (or pressure) is no longer there, participants 
may have returned to pre-programme patterns of behaviours that were problematic.  
 It is also interesting that levels of pain intensity, interference, depression, stress, 
and anxiety all increased post-programme, as these are all variables specifically targeted 
by the ReCharge Programme. On the other hand, levels of grit improved, and levels of 
hope and optimism were maintained, despite not being part of the programme. This leads 
one to wonder, is it better to attempt to decrease levels of vulnerabilities, increase levels 
of strengths, or target both concurrently?  
General Discussion 
 Chronic pain is a growing problem, and part of the solution is to figure out what 
things help or hinder chronic pain management. There has been much research into the 
different factors that affect chronic pain management, the relationships between 
vulnerabilities (depression, anxiety, stress, pessimism) and treatment outcome measures 
(pain catastrophising, pain intensity, interference pain self-efficacy, or strengths 
(optimism, hope, spirituality, social support, grit). There are also studies that look at the 
interactions between one or two vulnerabilities and one or two strengths and/or treatment 
outcome measures. We could not find any studies that look at all of these variables at the 
same time. 
Our study was designed to investigate changes in levels of treatment outcome 
measures, vulnerabilities, and strengths during the three-week ReCharge Programme 
and whether those changes were maintained at follow-up. We also analysed what the 
associations or correlations were between all of these different chronic pain variables. 
Overall, we found that participants levels of treatment outcome measures (excluding pain 
self-efficacy) and vulnerabilities decreased during the ReCharge Programme, while levels 
of pain self-efficacy and strengths increased. However, it did not appear that many of 





Learning that you are capable of much more than you believed you were can have 
a powerful effect on both maladaptive schema, such as those seen in pain 
catastrophising, and in a person’s confidence in their ability to complete daily tasks, as 
seen in pain self-efficacy. One of the fascinating things about pain catastrophising is that 
it is all based on a person’s beliefs about their pain, rather than the actual pain itself. As 
we talked about earlier, the fear of the intensity of the pain is much more debilitating than 
the actual level of pain intensity. Catastrophic thinking does not have a physical effect on 
the pain intensity, but it does have a psychological effect. Giving people the tools so that 
they can learn to recognise and counter such thinking could be a powerful mechanism of 
change where people are able to transition back into the workforce and re-engage with 
social and leisure activities. 
We found that optimism was the only strength significantly correlated with pain 
intensity, despite findings in the literature that hope, and social support were also 
associated with decreased levels of pain intensity (Berg et al., 2008). One reason for this 
discrepancy could be that in the experiments looking at the causal relationships between 
hope and levels of pain intensity, the pain was induced in a laboratory setting, these 
papers were looking at acute rather than chronic pain. The amount of time a person has 
been experiencing pain for, and the knowledge that one will continue experiencing this 
pain, may account for these differences. Undergoing a cold pressor task, where your 
hand is submerged in icy water for a set period of time is a very different pain experience. 
This research into the causal relationship is promising, there are few studies that can 
show directional causation between optimism or hope and pain intensity (Hanssen et al., 
2014; Snyder et al., 2005). Learning different coping strategies in the ReCharge 
Programme, while simultaneously putting those strategies in place, could in turn increase 
participants’ levels of optimism. Changing expectations about what the future may hold, 
learning that you are capable of more than you previously thought possible, may in turn 




We found that there were statistically significant associations between lower levels 
of pain catastrophising and higher levels of optimism, hope, spirituality, and grit. 
Increased levels of hope could be explained by the ReCharge Programme’s focus on 
setting and achieving goals, largely by making sure that the goals are realistic and that 
the efforts made to reach them are slow and steady rather than ‘boom or bust’. People 
living with chronic pain still often have good and bad days. On good days it can be 
tempting to try and do lots of things, but not necessarily helpful. Learning to pace yourself, 
regardless of your pain level, is much more adaptive than ‘booming’ on good days and 
then ‘busting’ on bad ones as a result of overdoing things (McCracken & Samuel, 2007). It 
is also more adaptive than not doing anything at all as avoiding movement and tasks can 
lead to higher levels of disability and psychological distress (Costa et al., 2011).  The 
ability to set and achieve goals is important in pain management, and goals are a core 
concept in hope theory (Coduti & Schoen, 2014). Attaining goals can contribute to 
increasing pain self-efficacy and decreasing pain catastrophising and interference.  
Not being able to achieve your goals can lead to negative emotions, and while 
hope is more of a cognitive process, we know that negative emotions can influence our 
thoughts (Snyder et al., 2000). Hope is broken down into pathway (how do you get to your 
goal) and agency (do you have the capacity to follow the pathway) (Snyder, 2002). For 
many people with chronic pain there can be multiple barriers on those pathways. In 
addition to the actual chronic pain itself, a lack in material and social resources can also 
bar the way. Having the mental and psychological flexibility to come up with a new 
pathway in the face of barriers can be difficult, but this is a skill that people can learn and 
utilise (Larsen et al., 2015). 
Although we only had a small sample, we saw statistically significant changes in 
nearly all variables from intake to discharge of the ReCharge Programme, whether they 
were targeted or not. Adding interventions aimed at increasing participants’ levels of 




seen in treatment outcome measures. These interventions could then be used after 
discharge from the programme in an attempt to maintain, or improve on, changes made 
during the programme. 
Limitations 
 There were a number of limitations within this research project. Firstly, the small 
sample size, which was largely due to the impact of COVID-19 lock down requirements 
during the course of this study. The measures that were used were all self-report 
measures, which always run the risk of implicit participant bias in their responses. In 
addition, there were a large number of measures participants needed to complete, and 
the measures were repeated at three different time points. The measures were given to 
participants in the same order at every time point, therefore, there may have been order 
effects. The Chronic Pain Wellbeing Survey was the final scale participants completed, 
which means that the way in which participants responded to these questions may have 
been influenced by the previous scales. Originally, we had wanted to include participants 
on a wait list as a control group, however, the ReCharge Programme did not have a wait 
list.  
Future Research 
 This study highlights the fact that chronic pain management is made up of multiple 
variables, which are highly individual and subjective. Being able to determine a client’s 
levels of vulnerabilities and strengths before they enter a pain management programme 
could lead to more targeted, and possibly more effective, interventions.  
  
Future research is needed on the causal and mediating relationships between 
treatment outcome measures, vulnerabilities, and strengths. It would also be helpful to be 
able to determine which vulnerabilities and strengths have the best predictive effect on 
treatment outcome measures. Finally, and ideally, future research should involve a double 
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Appendix A. QE Health and Spa Approach 
 
The ReCharge Programme 
QE Health (https://www.qehealth.co.nz/recharge) in Rotorua, New Zealand, runs a 
unique 3-week in-client pain management and rehabilitation programme. There is a 
strong focus on increasing problem solving and goal setting skills, which can then be 
generalised in the clients’ daily lives. QE Health have created a robust biopsychosocial 
model for an intensive pain management programme. They were interested in finding out 
which, if any, of the strengths being investigated in this study could be used to increase 
the efficacy of their programme for specific individuals. For example, are higher levels of 
optimism associated with lower levels of pain intensity? Are higher levels of hope 
associated with lower levels of pain interference? If such relationships are found, then QE 
Health could incorporate interventions in the ReCharge Programme to target factors such 





Appendix B. University of Waikato Human Research Ethics Committee Approval 
 
4 December 2019  
Eryn Campbell  
School of Psychology  
FASS  
 
By email: ejc24@students.waikato.ac.nz  
 
Dear Eryn  
 
HREC(Health)2019#34 : What is the relationship between changes in levels of 
positive and negative aspects of a person’s life and changes in levels of pain 
related measures for chronic pain patients?  
 
Thank you for submitting your amended research plan for HREC(Health)2019#34 for 
ethical approval.  
 
We are now pleased to provide formal approval for your project where you will carry out 
two forms of data collection:  
 
(1) collection of electronic data from patients attending the ReCharge pain management 
programme at Queen Margaret Hospital,  
(2) collection of paper-based data via Active+  
 
The project objectives are the same for each form of data collection: you will use the data 
to assess the relationship between pain levels of chronic pain patients, and other positive 
and negative aspects of these patients’ lives.  
Please contact the committee by email (humanethics@waikato.ac.nz) if you wish to make 
changes to your project as it unfolds, quoting your application number with your future 
correspondence. Any minor changes or additions to the approved research activities can 
be handled outside the monthly application cycle.  
 
 

















Kia ora, and thank you for your interest in this research project. 
 My name is Eryn Campbell and, like you, I suffer from chronic pain and have completed 
the ReCharge Programme. I am now a master’s student in the Clinical Psychology 
programme at the University of Waikato, Hamilton.  
This project is intended to determine if there is a relationship between changes in positive 
aspects of people’s lives and changes in their pain measurements while taking part in a 
pain management program. 
You have been invited to take part in this research because of your lived experience with 
chronic pain. This project may lead to a better understanding of how people living with 
chronic pain can improve their overall wellbeing, and your contribution will help me to do 
that. By participating in this research project, you are consenting to give me access to the 
information collected by QE Health at admission, discharge, and 3-month follow-up. 
This research is confidential, your identity will not be revealed at any time. Please contact 
either Robert on email Robert.isler@waikato.ac.nz or Eryn on 
email ejc24@waikato.students.ac.nz if you have any questions regarding this project.  
 If you take part in the study, you have the right to: 
• Stop answering questions at any time while completing the survey. 
• Withdraw from the study before analysis has commenced on the data, up to the 1st 
of August 2020. 
• Ask any further questions about the study that occur to you during your 
participation. 





I agree to take part in this research project and understand that by agreeing I am giving 
consent for Eryn Campbell to use both the data provided to QE Health and the additional 
questionnaires required for the project. 
 
Signed:           
 
Date:     
 
This research has been approved by the Human Research Ethics Committee (Health) of 
the University of the University of Waikato under HREC (Health) 2019#34. Any questions 
about the ethical conduct of this research may be addressed to the Secretary of the 
Committee, email humanethics@waikato.ac.nz, postal address, University of Waikato, Te 





Appendix D. The Pain Catastrophizing Scale 
PCS (Sullivan, Bishop, & Pivik, 1995) 
 
Everyone experiences painful situations at some point in their lives. Such experiences 
may include headaches, tooth pain or muscle pain. People are often exposed to situations 
that may cause pain such as illness, injury, dental procedures, or surgery. 
We are interested in the types of thoughts and feelings that you have when you are in 
pain. Listed below are thirteen statements describing different thoughts and feelings that 
may be associated with pain. Using the scale, please indicate the degree to which you 






























































1. I worry all the time about whether the pain will 
end. 
0 1 2 3 4 
2. I feel I can’t go on. 0 1 2 3 4 
3. It’s terrible and I think it’s never going to get 
any better. 
0 1 2 3 4 
4. It’s awful and I feel it overwhelms me. 0 1 2 3 4 
5. I feel I can’t stand it anymore. 0 1 2 3 4 
6. I become afraid that the pain will get worse. 0 1 2 3 4 
7. I keep thinking of other painful events. 0 1 2 3 4 
8. I anxiously want the pain to go away. 0 1 2 3 4 
9. I can’t seem to keep it out of my mind. 0 1 2 3 4 
10. I keep thinking about how much it hurts. 0 1 2 3 4 
11. I keep thinking about how badly I want the pain 
to stop. 
0 1 2 3 4 
12. There’s nothing I can do to reduce the intensity 
of the pain. 




13. I wonder whether something serious may 
happen. 





Appendix E. Brief Pain Inventory for Chronic Non-malignant Pain 
(Tan, Jensen., Thornby & Shanti, 2004) 
 
Rate your pain by selecting the one number that best describes the following (0 = 
No pain, and 10 = Pain as bad as you can imagine). 
1. Your pain at its worst in the last week? 0 1 2 3 4 5 6 7 8 9 10 
2. Your pain at its least in the last week? 0 1 2 3 4 5 6 7 8 9 10 
3. Your pain on average? 0 1 2 3 4 5 6 7 8 9 10 
4. How much pain do you have right now? 0 1 2 3 4 5 6 7 8 9 10 
 
During the past week, how much has pain interfered with the following? (0 = Does not 
interfere and 4 = Interferes completely ). 
1. Your general activity? 0 1 2 3 4       
2. Your mood? 0 1 2 3 4       
3. Your walking ability? 0 1 2 3 4       
4. Your normal work (both outside the home 
and housework)? 
0 1 2 3 4       
5. Your relations with other people? 0 1 2 3 4       
6. Your sleep? 0 1 2 3 4       






Appendix F. Pain Self Efficacy Questionnaire 
PSEQ (Nicholas, 2007) 
 
Please rate how confident you are that you can do the following things at present, 
despite the pain. To indicate your answer, select one of the numbers on the scale under 
each item, where 0 = not at all confident and 6 = completely confident. 
 
Remember, this questionnaire is not asking whether or not you have been doing these 
things, but rather how confident you are that you can do them AT PRESENT despite 
the pain. 
 
1 I can enjoy things, despite the pain 
 
0 1 2 3 4 5 6 
2 I can do most of the household chores (e.g., tidying up, 
washing dishes etc.), despite the pain 
0 1 2 3 4 5 6 
3 I can socialise with my friends or family members as often 
as I used to, despite the pain. 
0 1 2 3 4 5 6 
4 I can cope with my pain in most situations. 
 
0 1 2 3 4 5 6 
5 I can do some form of work, despite the pain (“work” 
includes housework, paid, and unpaid work). 
0 1 2 3 4 5 6 
6 I can still do many of the things I enjoy doing, such as 
hobbies or leisure activities. 
0 1 2 3 4 5 6 
7 I can cope with my pain without medication. 
 
0 1 2 3 4 5 6 
8 I can still accomplish most of my goals in life, despite the 
pain. 
0 1 2 3 4 5 6 
9 I can live a normal lifestyle, despite the pain. 
 
0 1 2 3 4 5 6 
10 I can gradually become more active, despite the pain. 
 







Appendix G. Depression Anxiety & Stress Scales  
DASS-21 (Henry & Crawford, 2005) 
 
Please read each statement and select a number 0, 1, 2 or 3 which indicates how much 
the statement applied to you OVER THE PAST WEEK. There are no right or wrong 
answers. Do not spend too much time on any statement. 
The rating scale is as follows: 
0. Did not apply to me at all 
1. Applied to me to some degree, or some of the time 
2. Applied to me a considerable degree or a good part of time 
3.  Applied to me very much or most of the time 
 
1. I found it hard to wind down. 0 1 2 3 
2. I was aware of dryness of my mouth 0 1 2 3 
3. I couldn’t seem to experience any positive 
feelings at all 
0 1 2 3 
4. I experienced breathing difficulty (e.g., 
excessively rapid breathing, breathlessness in 
the absence of physical exertion) 
0 1 2 3 
5. I found it difficult to work up the initiative to do 
things 
0 1 2 3 
6. I tended to over-react to situations 0 1 2 3 
7. I experienced trembling (e.g., in the hands) 0 1 2 3 
8. I felt that I was using a lot of nervous energy 0 1 2 3 
9. I was worried about situations in which I might 
panic and make a fool of myself 
0 1 2 3 
10. I felt that I had nothing to look forward to  0 1 2 3 
11. I found myself getting agitated 0 1 2 3 
12. I found it difficult to relax 0 1 2 3 
13. I felt downhearted and blue 0 1 2 3 
14. I was intolerant of anything that kept me from 
getting on with what I was doing 




15. I felt I was close to panic 0 1 2 3 
16. I was unable to become enthusiastic about 
anything 
0 1 2 3 
17. I felt I wasn’t worth much as a person 0 1 2 3 
18. I felt that I was rather touchy 0 1 2 3 
19. 
 
I was aware of the action of my heart in the 
absence of physical exertion (e.g., sense of 
heart rate increase, heart missing a beat) 
0 1 2 3 
20. I felt scared without any good reason 0 1 2 3 






Appendix H. Life Orientation Test Revised 
LOT-R (Scheier, Carver, & Bridges, 1994) 
 
Please be as honest and accurate as you can throughout. Try not to let your response to 
one statement influence your responses to other statements. There are no "correct" or 
"incorrect" answers. Answer according to your own feelings, rather than how you think 
"most people" would answer. 
 
1 = I agree a lot 
2 = I agree a little 
3 = I neither agree nor disagree 
4 = I disagree a little 
5 = I disagree a lot 
 
1. In uncertain times, I usually expect the best. 1 2 3 4 5 
2. It’s easy for me to relax. 1 2 3 4 5 
3. If something can go wrong for me, it will. 1 2 3 4 5 
4. I’m always optimistic about my future. 1 2 3 4 5 
5. I enjoy my friends a lot. 1 2 3 4 5 
6. It’s important for me to keep busy. 1 2 3 4 5 
7. I hardly ever expect things to go my way. 1 2 3 4 5 
8. I don’t get upset too easily. 1 2 3 4 5 
9. I rarely count on good things happening to me. 1 2 3 4 5 





Appendix I. The Adult Trait Hope Scale 
(Snyder et al., 1991) 
 
Directions: Read each item carefully. Using the scale shown below, please select the 
number that best describes YOU TODAY. 
   1. = Definitely False 
   2. = Mostly False 
   3. = Somewhat False 
   4. = Slightly False 
   5. = Slightly True 
   6. = Somewhat True 
   7. = Mostly True 
   8. = Definitely True 
 
 
1. I can think of many ways to get out of a jam. 1 2 3 4 5 6 7 8 
2. I energetically pursue my goals. 1 2 3 4 5 6 7 8 
3. I feel tired most of the time. 1 2 3 4 5 6 7 8 
4. There are lots of ways around any problem. 1 2 3 4 5 6 7 8 
5. I am easily downed in an argument. 1 2 3 4 5 6 7 8 
6. I can think of many ways to get the things in life that 
are important to me. 
1 2 3 4 5 6 7 8 
7. I worry about my health. 1 2 3 4 5 6 7 8 
8. Even when others get discouraged, I know I can find 
a way to solve the problem. 
1 2 3 4 5 6 7 8 
9. My past experiences have prepared me well for my 
future. 
1 2 3 4 5 6 7 8 
10. I’ve been pretty successful in life. 1 2 3 4 5 6 7 8 




12. I meet the goals that I set for myself. 1 2 3 4 5 6 7 8 
Appendix J. Spirituality Scale 
(Delaney, 2005) 
 
Please indicate your level of agreement to the following statements by selecting the 
appropriated number that corresponds with the scale below. 
 
1. Strongly disagree 
2. Disagree 
3. Mostly disagree 
4. Mostly agree 
5. Agree 
6. Strongly agree 
 
1. I find meaning in my life experiences. 1 2 3 4 5 6 
2. I meditate to gain access to my inner spirit. 1 2 3 4 5 6 
3. I believe there is a connection between all things that I cannot 
see but can sense. 
1 2 3 4 5 6 
4. I believe in a Higher Power / Universal Intelligence. 1 2 3 4 5 6 
5. I believe that all living creatures deserve respect. 1 2 3 4 5 6 
6. I value maintaining and nurturing my relationship with others. 1 2 3 4 5 6 
7. I use silence to get in touch with myself. 1 2 3 4 5 6 
8. My spirituality gives me inner strength. 1 2 3 4 5 6 
9. I am able to receive love from others. 1 2 3 4 5 6 





Appendix K. Duke-UNC Functional Social Support Questionnaire 
FSSQ (Broadhead, Gehlbach, De Gruy, & Kaplan, 1988) 
 
Here is a list of some things that other people do for us or give us that may be helpful or 
supportive. Please read each statement carefully and select the answer that is closest to 
your situation.  
 
5 = As much as I would like 
4 = Almost as much as I would like 
3 = Some, but would like more 
2 = Less than I would like 
1 = Much less than I would like 
 
1. I have people who care what happens to me. 5 4 3 2 1 
2. I get love and affection 5 4 3 2 1 
3. I get chances to talk to someone about problems at work or with 
my housework. 
5 4 3 2 1 
4. I get a chance to talk to someone I trust about my personal or 
family problems. 
5 4 3 2 1 
5. I get chances to talk about money matters. 5 4 3 2 1 
6. I get invitations to go out and do things with other people. 5 4 3 2 1 
7. I get useful advice about important things in life. 5 4 3 2 1 
8. I get help when I am sick in bed. 5 4 3 2 1 






Appendix L. Short Grit Scale 
(Duckworth & Quinn, 2009) 
 
Here are a number of statements that may or may not apply to you. For the most accurate 
score, when responding, think of how you compare to most people – not just the people 
you know well, but most people in the world. There are no right, or wrong answers so just 
answer honestly. Select the most appropriate number from the list below for each 
question. 
 
1 = Very much like me 
2 = Mostly like me 
3 = Somewhat like me 
4 = Not much like me 
5 = Not like me at all 
 
 
1. New ideas and projects sometimes distract me from 
previous ones 
1 2 3 4 5 
2. Setbacks don’t discourage me 1 2 3 4 5 
3. I have been obsessed with a certain idea or project for a 
short time but later lost interest 
1 2 3 4 5 
4. I am a hard worker 1 2 3 4 5 
5. I often set a goal, but later choose to pursue a different 
one 
1 2 3 4 5 
6. I have difficulty maintaining my focus on projects that 
take more than a few months to complete 
1 2 3 4 5 
7. I finish whatever I begin 1 2 3 4 5 





Appendix M. Chronic Pain Wellbeing Scale 
 
Please read each statement and choose the response that best describes you right now. 
































































1.New ideas and projects sometimes distract me from 
previous ones. 
1 2 3 4 5 
2. Setbacks don’t discourage me 
 
1 2 3 4 5 
3. I have been obsessed with a certain idea or project for a 
short time but later lost interest.  
1 2 3 4 5 
4. I am a hard worker 
 
1 2 3 4 5 
5. I often set a goal but later chose to pursue a different one 
 
1 2 3 4 5 
6. I have difficulty maintaining my focus on projects that take 
more than a few months to complete 
1 2 3 4 5 
7. I finish whatever I begin 
 
1 2 3 4 5 
8. I am diligent 
 
1 2 3 4 5 
9. I have people who care what happens to me 
 




10. I get love and affection 
 
1 2 3 4 5 
11. I get chances to talk to someone about problems at work 
or with my housework 
1 2 3 4 5 
12. I get chances to talk to someone I trust about my 
personal or family problems 
1 2 3 4 5 
13. I get chances to talk about money matters 
 
1 2 3 4 5 
14. I get invitations to go out and do things with other people 
 
1 2 3 4 5 
15. I get useful advice about important things in my life 
 
1 2 3 4 5 
16. I get help when I am sick in bed 
 
1 2 3 4 5 
17. In uncertain times, I usually expect the best 
 
1 2 3 4 5 
18. If something can go wrong for me, it will 
 
1 2 3 4 5 
19. I’m always optimistic about my future 
 
1 2 3 4 5 
20. I hardly ever expect things to go my way 
 






























































21. I rarely count on good things happening to me 
 




22. Overall, I expect more good things to happen to me than 
bad 
1 2 3 4 5 
23. I can think of many ways to get out of a jam 
 
1 2 3 4 5 
24. I energetically pursue my goals 
 
1 2 3 4 5 
25. There are lots of ways around any problem 
 
1 2 3 4 5 
26. I can think of many ways to get the things in life that are 
important to me 
1 2 3 4 5 
27. Even when others get discouraged, I know I can find a 
way to solve the problem 
1 2 3 4 5 
28. My past experiences have prepared me well for my future 
 
1 2 3 4 5 
29. I’ve been pretty successful in life 
 
1 2 3 4 5 
30. I meet the goals that I set for myself 
 
1 2 3 4 5 
31. I find meaning in my life experiences 
 
1 2 3 4 5 
32. I have a sense of purpose 
 
1 2 3 4 5 
33. I am happy about the person I have become 
 
1 2 3 4 5 
34. I see the sacredness in everyday life 
 
1 2 3 4 5 
35. I believe there is a connection between all things that I 
can sense but cannot see 
1 2 3 4 5 
36. I believe that all living creatures deserve respect 
 




37. I value maintaining and nurturing my relationships with 
others 
1 2 3 4 5 
38. My spirituality gives me inner strength 
 
1 2 3 4 5 
39. I am able to receive love from others 
 
1 2 3 4 5 
40. My faith in a Higher Power / Universal Intelligence helps 
me cope during challenges in my life 
1 2 3 4 5 
 
 
 
